OBJECTIVE: To safely and effectively train the exercise capacity of post-COVID-19 patients it is important to test for cardiopulmonary risk factors and to assess exercise limitations. The goal of this study was to describe the exercise capacity and underlying exercise limitations of mechanically ventilated post-COVID-19 patients in clinical rehabilitation. DESIGN: A retrospective cohort study. METHOD: Twenty-four post-COVID-19patients that were mechanically ventilated at ICU and thereafter admitted for clinical rehabilitation performed a symptom-limited cardiopulmonary exercise test (CPET) with breath-by-breath gas-exchange monitoring, ECG-registration, blood pressure- and saturation monitoring. In absence of a primary cardiac or ventilatory exercise limitation patients were considered to be limited primarily by decreased peripheral muscle mass. RESULTS: Twenty-three patients could perform a maximal exercise test and no adverse events occurred. Cardiorespiratory fitness was very poor with a median peak oxygen uptake of 15.0 [10.1-21.4] mlO2/kg/min (57% of predicted values). However, we observed large differences within the group in both exercise capacity and exercise limitations. While 7/23 patients were primarily limited by ventilatory function, the majority (70%) was limited primarily by the decreased peripheral muscle mass. CONCLUSION: Cardiorespiratory fitness of post-COVID-19 patients in clinical rehabilitation is strongly deteriorated. The majority of patients seemed primarily limited for exercise by the decreased peripheral muscle mass.
OBJECTIVE: To safely and effectively train the exercise capacity of post-COVID-19patients it is important to test for cardiopulmonary risk factors and to assess exercise limitations. The goal of this study was to describe the exercise capacity and underlying exercise limitations of mechanically ventilated post-COVID-19patients in clinical rehabilitation. DESIGN: A retrospective cohort study. METHOD: Twenty-four post-COVID-19patients that were mechanically ventilated at ICU and thereafter admitted for clinical rehabilitation performed a symptom-limited cardiopulmonary exercise test (CPET) with breath-by-breath gas-exchange monitoring, ECG-registration, blood pressure- and saturation monitoring. In absence of a primary cardiac or ventilatory exercise limitation patients were considered to be limited primarily by decreased peripheral muscle mass. RESULTS: Twenty-three patients could perform a maximal exercise test and no adverse events occurred. Cardiorespiratory fitness was very poor with a median peak oxygen uptake of 15.0 [10.1-21.4] mlO2/kg/min (57% of predicted values). However, we observed large differences within the group in both exercise capacity and exercise limitations. While 7/23 patients were primarily limited by ventilatory function, the majority (70%) was limited primarily by the decreased peripheral muscle mass. CONCLUSION:Cardiorespiratory fitness of post-COVID-19patients in clinical rehabilitation is strongly deteriorated. The majority of patients seemed primarily limited for exercise by the decreased peripheral muscle mass.
Authors: Beatriz Carpallo-Porcar; Laura Romo-Calvo; Sara Pérez-Palomares; Carolina Jiménez-Sánchez; Pablo Herrero; Natalia Brandín-de la Cruz; Sandra Calvo Journal: PLoS One Date: 2022-07-19 Impact factor: 3.752
Authors: Jaime Vásquez-Gómez; César Faúndez-Casanova; Ricardo Souza de Carvalho; Franklin Castillo-Retamal; Pedro Valenzuela Reyes; Yeny Concha-Cisternas; Pablo Luna-Villouta; Cristian Álvarez; Andrés Godoy-Cumillaf; Claudio Hernández-Mosqueira; Igor Cigarroa; Alex Garrido-Méndez; Carlos Matus-Castillo; Marcelo Castillo-Retamal; Ivana Leao Ribeiro Journal: Int J Environ Res Public Health Date: 2022-06-03 Impact factor: 4.614
Authors: Virginia L Mihalick; Justin M Canada; Ross Arena; Antonio Abbate; Danielle L Kirkman Journal: Prog Cardiovasc Dis Date: 2021-05-06 Impact factor: 8.194
Authors: Anna Boehm; Anna K Luger; Katja Schmitz; Katharina Cima; Daniel Hölbling Patscheider; Florian Augustin; Lisa Maria Jakob; Astrid Obermayer; Guenter Weiss; Walter Stoiber; Gerlig Widmann; Judith Loeffler-Ragg Journal: Infection Date: 2021-08-25 Impact factor: 3.553
Authors: Madu N Soares; Moritz Eggelbusch; Elie Naddaf; Karin H L Gerrits; Marike van der Schaaf; Bram van den Borst; W Joost Wiersinga; Michele van Vugt; Peter J M Weijs; Andrew J Murray; Rob C I Wüst Journal: J Cachexia Sarcopenia Muscle Date: 2022-01-07 Impact factor: 12.910